Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers, Eli Lilly, GlaxoSmithKline, J&J, Merck, Merck KGaA, Novartis, Novo Nordisk, Roche, Sanofi, Taked

IMI launched the GETREAL project to help companies generate realworld data for payers during the drug development process, along with the clinical data necessary for regulatory approval. Topics for the project include designing clinical trials that generate real-world effectiveness data and developing tools and methods that measure a drug's effectiveness during a trial in a way that reflects clinical practice. Other stakeholders - including patient groups, health technology assessment (HTA) agencies and payers - will also provide input and will be part of a network of "healthcare decision makers." ...